Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The study record now lists NIH grant/contract notes for 2019 and 2023. The page shows an updated revision tag, Revision: v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T06:16:55.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    No textual changes were provided in the change data, so the page content remains unchanged based on the input.
    Difference
    0.0%
    Check dated 2026-08-23T02:58:24.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now displayed on the page, replacing the prior version. This indicates a minor, system-level update to the page rather than a substantive change to the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-08T23:15:17.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.4, reflecting a minor internal update to the ClinicalTrials.gov interface. No study data, eligibility criteria, or results content were changed.
    Difference
    0.0%
    Check dated 2026-07-25T13:26:38.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.6.3 replaces v3.6.2 on the page, signaling a small update to the page's version history rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-07-04T00:00:15.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a minor update to the page metadata. This does not modify study content, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-06-26T23:48:29.000Z thumbnail image

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.